The FDA has issued a warning letter to Torrent Pharmaceuticals regarding problems at a losartan manufacturing plant in India as part of its investigation into contaminated hypertension drugs.
A new analysis warns that the FDA has only screened a quarter of all valsartan and similar high blood pressure medications for cancer-causing impurities.
A losartan lawsuit claims generic versions of the drug were tainted with impurities which caused colon cancer.
The FDA is expanding its hunt for cancer-causing impurities in drugs beyond hypertension medications like valsartan.
A wrongful death lawsuit names a large number of generic drug manufacturers as liable for the death of a Texas man who contracted a fatal case of gastric cancer after…
A solvent company in India received a warning letter from the FDA, indicating it may have played a role in massive generic valsartan recalls issued over cancer-causing impurities.
A wrongful death lawsuit blames recalled generic valsartan for a man's fatal case of stomach cancer.
A prostate cancer lawsuit filed against the makers of generic valsartan say tainted pills caused a man's cancer to return and spread to his bones.
A valsartan lawsuit claims cancer-causing impurities in recalled generic tablets resulted in kidney cancer and the need for kidney removal.
A new study questions the increase in cancer-related reports linked to valsartan following a series of recalls that began last summer, saying they may have been the result of alarm…
